AU2100901A - Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation - Google Patents

Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation

Info

Publication number
AU2100901A
AU2100901A AU21009/01A AU2100901A AU2100901A AU 2100901 A AU2100901 A AU 2100901A AU 21009/01 A AU21009/01 A AU 21009/01A AU 2100901 A AU2100901 A AU 2100901A AU 2100901 A AU2100901 A AU 2100901A
Authority
AU
Australia
Prior art keywords
kits
inhibiting
compositions
methods
cephalic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21009/01A
Inventor
Bruce H. Levin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2100901A publication Critical patent/AU2100901A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/07—General characteristics of the apparatus having air pumping means
    • A61M2205/071—General characteristics of the apparatus having air pumping means hand operated
    • A61M2205/075—Bulb type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/06—Head
    • A61M2210/0618—Nose
AU21009/01A 1999-12-15 2000-12-15 Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation Abandoned AU2100901A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17081799P 1999-12-15 1999-12-15
US60170817 1999-12-15
PCT/US2000/033916 WO2001043733A2 (en) 1999-12-15 2000-12-15 Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation

Publications (1)

Publication Number Publication Date
AU2100901A true AU2100901A (en) 2001-06-25

Family

ID=22621377

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21009/01A Abandoned AU2100901A (en) 1999-12-15 2000-12-15 Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation

Country Status (2)

Country Link
AU (1) AU2100901A (en)
WO (1) WO2001043733A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6853858B2 (en) 2000-05-08 2005-02-08 Brainsgate, Ltd. Administration of anti-inflammatory drugs into the central nervous system
US7684859B2 (en) 2002-04-25 2010-03-23 Brainsgate Ltd. Stimulation of the OTIC ganglion for treating medical conditions
GB0312844D0 (en) * 2003-06-04 2003-07-09 Paradigm Therapeutics Ltd Use of compounds in medicine
DE10358749A1 (en) * 2003-12-12 2005-07-14 Lts Lohmann Therapie-Systeme Ag Dosage form for combating primary headache
US8055347B2 (en) 2005-08-19 2011-11-08 Brainsgate Ltd. Stimulation for treating brain events and other conditions
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation
US8010189B2 (en) 2004-02-20 2011-08-30 Brainsgate Ltd. SPG stimulation for treating complications of subarachnoid hemorrhage
US7860569B2 (en) 2007-10-18 2010-12-28 Brainsgate, Ltd. Long-term SPG stimulation therapy for prevention of vascular dementia
ITTO20110576A1 (en) 2011-06-30 2012-12-31 Medicam Health Science S R L COMPOSITION INCLUDING THE ASSOCIATION OF MELISSA PHYTO-EXTRACT, METHYLAMIDE AND A SOURCE OF NUCLEOTIDES AND / OR NUCLEOSIDES AND ITS USE IN THE TREATMENT OF HEADACHE AND HEMICRYANES
EP2878335B1 (en) 2013-11-10 2018-01-03 Brainsgate Ltd. Implant and delivery system for neural stimulator
EP3093043B1 (en) 2015-05-13 2018-11-14 Brainsgate Ltd. Implant and delivery system for neural stimulator
TR201604127A2 (en) * 2016-03-30 2016-08-22 Endemesis Ilac Sanayi Ve Ticaret Use of composition that contains local anesthetic for treating nausea
WO2024023676A1 (en) * 2022-07-28 2024-02-01 Cochlear Limited Techniques for providing stimulus for tinnitus therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19526019A1 (en) * 1995-07-17 1997-01-23 Liedtke Pharmed Gmbh Method and composition of a topical therapy for headache
BE1009851A3 (en) * 1996-01-11 1997-10-07 Thiebauld Charles Marie Pharmaceutical composition for the treatment of headaches and use of same
GB2315673A (en) * 1996-08-01 1998-02-11 Merck & Co Inc Treatment of migraine
GB9704349D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
TR200000149T2 (en) * 1997-07-21 2000-05-22 Astra Aktiebolag Compositions for the prevention of cerebral neurovascular disorders, muscular headaches
SE9704770D0 (en) * 1997-12-19 1997-12-19 Astra Ab New use
AU2862200A (en) * 1999-01-27 2000-08-18 Bruce H. Levin Compositions, kits, apparatus, and methods for inhibiting cerebral neurovasculardisorders and muscular headaches

Also Published As

Publication number Publication date
WO2001043733A2 (en) 2001-06-21
WO2001043733A3 (en) 2002-05-10

Similar Documents

Publication Publication Date Title
AU2862200A (en) Compositions, kits, apparatus, and methods for inhibiting cerebral neurovasculardisorders and muscular headaches
AU6940300A (en) Self-spotting apparatus for free-weights
AU4048000A (en) Service rate change method and apparatus
AU2409800A (en) Protective coating and methods for making same
AU1154301A (en) Apparatus and method for coating pipes
AU4784500A (en) Reduction apparatus
AU7859900A (en) Compositions and methods for wt1 specific immunotherapy
AU5294100A (en) Method and compositions for treating the inflammatory response
AU3901100A (en) Method and composition for waterproofing
AU3077699A (en) Apparatus for performing hippotherapy
AU7636600A (en) Slide apparatus
AU3877900A (en) Compositions and methods for preventing and treating sexual dysfunctions
AU1222801A (en) Method and apparatus for testing plumbing installations
AU5483100A (en) Equipment securing apparatus
AU2100901A (en) Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
AU3869200A (en) Method and composition for masking mineral taste
AU1029501A (en) Cleaning-in-place composition and method for using the same
AU4033900A (en) Compositions and methods for treating cell proliferation disorders
AU3235100A (en) Prothease inhibitors
AU2037101A (en) Method for immobilisation
AU2664400A (en) Method and apparatus for making flakes
AU6418400A (en) Apparatus for musical composition
AUPP979099A0 (en) Ioniser for effluent gas
AU4809000A (en) Method and composition for waterproofing
AU6798000A (en) Compounds, compositions and methods for treating influenza

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase